image
Champions Oncology, Inc. CSBR
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.5
0.897 %
$ 61.2 M
Market Cap
-17.31
P/E
BALANCE SHEET
26.1 M ASSETS
-23.84%
Growth Rates
1Year -23.84%
3Years -1.79%
5Years 18.33%
7Years 18.40%
10Years 11.41%
28 M LIABILITIES
-5.53%
Growth Rates
1Year -5.53%
3Years 11.61%
5Years 25.44%
7Years 20.47%
10Years 17.33%
-1.9 M EQUITY
-41.05%
Growth Rates
1Year -41.05%
3Years -7.90%
5Years -13.10%
7Years -28.41%
10Years -4.78%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Champions Oncology, Inc.
image
Current Assets 13.6 M
Cash & Short-Term Investments 2.62 M
Receivables 9.53 M
Other Current Assets 1.5 M
Non-Current Assets 12.5 M
Long-Term Investments 0
PP&E 12 M
Other Non-Current Assets 520 K
Current Liabilities 21.5 M
Accounts Payable 5.8 M
Short-Term Debt 2.67 M
Other Current Liabilities 13.1 M
Non-Current Liabilities 6.49 M
Long-Term Debt 6.09 M
Other Non-Current Liabilities 401 K

Balance Sheet

Millions
Apr-2024 Apr-2023 Apr-2022 Apr-2021 Apr-2020 Apr-2019 Apr-2018 Apr-2017 Apr-2016 Apr-2015 Apr-2014 Apr-2013 Apr-2012 Apr-2011 Apr-2010 Apr-2009 Apr-2008 Apr-2007 Apr-2006 Apr-2005 Apr-2004 Apr-2003 Apr-2002 Apr-2001 Apr-2000 Apr-1999 Apr-1998 Apr-1997 Apr-1996
ASSETS
Cash & Cash Equivalents 2.6 10.1 9.0 4.7 8.3 3.2 0.9 3.3 2.6 9.4 5.9 9.6 4.8 10.5 2.6 1.7 3.7 3.76 K 540 84.5 K 0.1 0.2 0.4 0.5 0.6 0.7 0.6 0.2 0.1
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.0 0 0 0 0 0 0 0 0 0 0 0 0 30 K
Receivables 9.5 8.0 9.5 7.0 4.8 4.4 3.9 2.3 1.3 1.1 1.3 0.5 0.6 1.1 46 K 0 0 0 0 0 22.7 K 0 54 1.33 K 0.1 0 0 20 K 10 K
Inventory 0 1 0 0 1 1 1 1 1 0 0 1 0 0 0 0 0 0 0 18.5 K 30.3 K 23.8 K 25.6 K 25.1 K 24.2 K 20 K 70 K 60 K 50 K
Other Current Assets 1.5 1.3 2.3 1.0 0.4 0.6 0.6 0.6 0.9 0.7 0.8 0.3 0.4 0.3 1.0 2.2 52.9 K 0 0 0 6.75 K 10.8 K 14 K 17.4 K 0.2 0.2 0.2 0.2 20 K
Total Current Assets 13.6 19.5 19.7 12.6 13.5 7.9 5.1 5.9 4.3 10.8 7.6 10.4 5.5 11.8 3.2 3.9 3.8 3.76 K 540 0.1 0.2 0.2 0.5 0.5 1.0 1.0 0.9 0.6 0.2
PP&E 12.0 14.5 15.4 14.6 6.8 2.5 2.1 1.2 0.6 0.5 0.4 0.4 0.6 0.1 0.1 81 K 0 0 0 0.2 0.2 0.2 0.3 0.3 0.3 0.4 0.4 0.4 0.5
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0.2 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0.3 0.3 0.3 0.3 0.3 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0.1 (21.8) (19.1) (15.2) (11.0) (8.9) (6.4) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.2 15 K 15 K 15 K 0.1 0.1 0.3 0.3 0.1 0.2 0.2 0.2 0.1 (3.6) 0 0 0 0 0 11.1 K 11.1 K 11.1 K 11.1 K 61.1 K 0.1 10 K 20 K 10 K 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 1 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 26.1 34.3 35.4 27.6 20.8 11.3 8.1 8.0 5.8 12.0 8.9 11.7 6.9 12.7 3.9 4.6 4.7 0.2 540 0.3 0.4 0.5 0.8 0.9 1.4 1.4 1.3 1.0 0.7
LIABILITIES
Accounts Payable 5.8 5.3 2.9 1.9 3.1 2.8 2.2 1.9 1.9 1.4 1.0 1.2 1.7 1.6 0.9 1.4 0.1 49.7 K 33.3 K 69.5 K 92.8 K 65.2 K 88.1 K 0.1 48.2 K 40 K 40 K 50 K 50 K
Short Term Debt 2.7 2.4 2.1 0.8 0.6 16 K 26 K 0 0 0 0 0 0 0 0 0 0 43.7 K 0 0 0 0 6.29 K 14.6 K 12.8 K 0 0 0 0
Other Current Liabilities 1.0 1.2 1.4 2.2 2.7 1.2 0.6 0.7 0.3 0.4 0.6 0.6 0.6 0.3 0.2 67 K 0.4 0.4 0.6 0.6 0.4 0.6 0.6 0.5 0.4 0.4 0.3 0.3 0.2
Total Current Liabilities 21.5 21.7 17.5 11.2 12.1 8.0 7.5 7.4 5.3 3.8 3.7 3.0 3.5 3.5 2.1 2.7 1.0 0.4 0.7 0.6 0.5 0.7 0.8 0.7 0.5 0.4 0.4 0.3 0.3
Long Term Debt 6.1 7.4 8.4 8.8 3.2 0 17 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.88 K 7.2 K 13.5 K 28.5 K 20 K 0 0 10 K
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0.4 0.6 0.4 0.2 0.2 1.0 0.6 0.2 0.2 0.2 2.0 1.0 0.6 9.1 0.3 0 0 0 0 0 0 0 0 0 0 20 K 30 K 30 K 40 K
Total Liabilities 28.0 29.7 26.3 20.2 15.4 9.0 8.1 7.6 5.5 4.0 5.7 4.1 12.2 12.6 2.4 2.7 1.0 0.4 0.7 0.6 0.5 0.7 0.8 0.7 0.5 0.5 0.4 0.3 0.3
EQUITY
Common Stock 14 K 14 K 14 K 13 K 13 K 12 K 11 K 11 K 9 K 0.1 70 K 39 K 38 K 37 K 37 K 34 K 33.2 K 27.6 K 16.8 K 16.8 K 8.82 K 8.51 K 8.51 K 8.51 K 8.51 K 10 K 10 K 10 K 10 K
Retained Earnings (84.6) (77.3) (72.0) (72.5) (72.7) (70.7) (70.8) (69.3) (62.5) (52.0) (38.9) (31.5) (25.1) (16.5) (12.7) (9.8) (7.1) (7.1) (6.9) (6.6) (6.3) (6.1) (5.9) (5.7) (5.0) (5.0) (4.9) (5.2) (5.4)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 (1.5) (1.1) (1.0) (0.8) 0 100 K (0.1) 68 K 4 K 4 K (1.0) 33.1 K 0 (0.9) (0.9) (0.9) (0.9) (0.8) (0.8) (0.7) (0.7) (0.6) (0.6)
Total Equity (1.9) 4.6 9.1 7.4 5.3 2.2 25 K 0.4 0.2 8.1 3.2 7.6 (5.3) 19 K 1.6 1.9 3.6 (0.3) (0.7) (0.4) 92.7 K (0.2) 5 K 0.2 0.9 0.9 0.9 0.7 0.4
Total Liabilities and Equity 26.1 34.3 35.4 27.6 20.8 11.3 8.1 8.0 5.8 12.0 8.9 11.7 6.9 12.7 3.9 4.6 4.7 0.2 540 0.3 0.4 0.5 0.8 0.9 1.4 1.4 1.3 1.0 0.8
SHARES OUTSTANDING
Common Shares Outstanding 13.5 13.5 13.2 13.1 11.8 11.3 11.0 10.7 8.7 8.7 5.6 3.0 3.9 2.8 2.8 2.8 2.6 1.7 1.4 1.1 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7